News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    

Biotech/Pharma - Patent News
PDL BioPharma (PDLI) Announces Settlement Of Keytruda Patent Infringement Lawsuit With Merck & Co. (MRK) 4/24/2017
Oramed (ORMP) Granted European Patent For Combination Oral Insulin And GLP-1 Analog Capsule 4/20/2017
BioRestorative Receives Notice Of Acceptance For Key Metabolic Patent In Australia 4/20/2017
Argentum And Allergan (AGN) Settle Patent Dispute Over RESTASIS 4/19/2017
Egaceutical Corporation Demonstrates Human Age Reversal, Patent Is Pending 4/19/2017
Pluristem Therapeutics (PSTI) Reaches Milestone Of 100 Granted Patents, Including Coverage Of Leading Indications In Major Markets 4/19/2017
Spherix (SPEX) Announces Economic Interest Acquired In New Patent Portfolio 4/19/2017
EyeLock Receives Patent For Mobility Identity Platforms 4/19/2017
Kura Oncology Granted U.S. Patent For Clinical-Stage ERK Inhibitor, KO-947 4/19/2017
Spectro Scientific Wins Patent For Extending Lasernet Fines Particle Analysis Technology With Ferrous Particle Measurement Capability 4/19/2017
Biocept (BIOC) Awarded Additional Patent In Japan Expanding Intellectual Property Estate To 19 Issued Patents Protecting Its Target Selector Liquid Biopsy Platform 4/18/2017
Cellectar Biosciences  (CLRB) Receives Japanese Patent For CLR 131 And CLR 125 For The Treatment Of Cancer Stem Cells 4/18/2017
Santalis Announces Issuance Of An Australian Patent Covering The Use Of Sandalwood Oil To Treat Cancers 4/18/2017
RedHill Biopharma (RDHL) Receives Notice Of Allowance For Two Additional U.S. Patents Covering BEKINDA 4/18/2017
Repros Therapeutics (RPRX) Announces The Issuance Of New U.S. Patent Relating To Treatment Using Off Drug Intervals For Certain Uterine Conditions 4/17/2017
Helius Medical Technologies Receives Two Medical Method Patents 4/17/2017
LegoChem Biosciences Receives U.S. Patent For Its Own Proprietary ADC Platform Technology ConjuAll 4/17/2017
Incysus Granted European Patent Covering Its Drug Resistant Immunotherapy (DRI) Technology 4/13/2017
BioMarin (BMRN) Announces Kuvan (sapropterin dihydrochloride) Patent Challenge Settlement 4/13/2017
Innovus Pharma Receives Patent For Its Sensum+ Product In Morocco 4/12/2017
Synergy Pharma (SGYP) Announces Issuance Of Three New Patents Expected To Extend TRULANCE (Plecanatide) Patent Protection Until 2032 4/12/2017
Intellia Announces European Patent Office’s Decision to Grant CRISPR/Cas9 Genome Editing Technology Patent 4/11/2017
Hi-Tech Pharmacal (HITK) Wins Almost $1 Million In Legal Fees From Thermolife And Stanford University After Winning Major Patent Case 4/10/2017
Intellipharmaceutics (IPCI) Announces Patent Litigation By Purdue Pharma L.P. Against Its Rexista Abuse-Deterrent Extended-Release Oxycodone 4/10/2017
KFx Medical Announces Another And Third License Of Its Knotless Double Row Patents 4/7/2017
IBM (IBM) Patents Machine Learning Models For Drug Discovery 4/7/2017
Jazz Pharma (JAZZ) Reaches Settlement With Hikma (HIK.L) Related To Xyrem Patent Litigation 4/6/2017
APR Applied Pharma Research S.A. Wants To Make The Difference For PKU People Thanks To An Innovative And Patented Technology 4/6/2017
SpinalCyte, LLC Receives New European Patent 4/6/2017
Creative Medical Technology Files Patent On Reducing Radiation Toxicity Using AmnioStem Universal Donor Stem Cell Product 4/5/2017
Neothetics (NEOT) Announces Issuance By USPTO Of Eighth Patent Directed To LIPO-202 Lead Clinical Asset 4/5/2017
Varian Medical Systems (VAR) And Elekta Settle Patent Litigation 4/4/2017
AbbVie (ABBV) Accuses Novartis AG (NVS) Of Trying To Patent The Hep C Virus 4/4/2017
Patent Case Of Carl Zeiss Meditec AG (AFX.DE) And VSY Biotechnology B.V. 4/4/2017
Diffusion Pharma Awarded U.S. Patent For TSC As Therapeutic In Five Hypoxia-Related Indications 4/4/2017
Aclaris (ACRS) Announces Notice Of Allowance For Two U.S. Patent Applications Covering Baricitnib And Decernotinib, Respectively, For Hair Loss Disorders 4/4/2017
Interpace Diagnostics Announces European Patent Approval For Underlying Technology Of Its Thyramir Microrna Classifier 4/3/2017
ProQR Therapeutics B.V. (PRQR) Announces The Grant Of Two Key Patents, Protecting QR-010 For Cystic Fibrosis In The U.S. And EU 4/3/2017
Forward Pharma (FWP) Intends To Appeal Decision In Patent Interference Proceeding With Biogen (BIIB) 4/3/2017
United Therapeutics (UTHR) Announces Decision From Patent Trial And Appeal Board And Issuance Of New Patents 4/3/2017
Sunovion Announces Utibron Neohaler (Indacaterol/Glycopyrrolate) Inhalation Powder Now Available In The United States 4/3/2017
Cardiome Pharma Corp. (COM.TO)'s Partner SteadyMed Receives Favourable Ruling In Its USPTO Inter Partes Review 4/3/2017
Treos Bio Announces Filing Of Key Patent Applications On Its Precision Therapeutic Cancer Vaccine Development Platform And Its Compositions For Colorectal And Breast Cancers 4/3/2017
SteadyMed (STDY) Receives Favorable Ruling In Inter Partes Review Against United Therapeutics (UTHR) Patent 4/3/2017
BioDelivery (BDSI) Announces The Granting Of Two New Patents To Be Listed In FDA's Orange Book Further Extending And Strengthening Patent Protection On BELBUCA, BUNAVAIL And ONSOLIS 3/31/2017
IMPAX Labs (IPXL) Announces Favorable Ruling Regarding Patent Validity For Zomig (Zolmitriptan) Nasal Spray 3/31/2017
Acorda (ACOR) Release: U.S. District Court Issues Decision To Invalidate Four Ampyra Patents; Company Will Appeal Ruling 3/31/2017
Pivot Pharmaceuticals Announces Receipt Of Notice Of Allowance From The United States Patent And Trademark Office 3/30/2017
Immune Therapeutics Announces Expansion Of Patent Portfolio 3/30/2017
CortControl Granted U.S. Patent For Vaccine Immuno-Enhancement Treatment For At-Risk Global Populations 3/29/2017
Key BioTime (BTX) Patents Upheld By European Patent Office 3/28/2017
CytoSorbents Strengthens Intellectual Property Portfolio With New Patents Issued In The U.S., China, Japan, Russia, And Australia 3/28/2017
ERS Genomics Release: European Patent Office To Grant Broad Claims On Patent Covering CRISPR-Cas9 Gene Editing Technology 3/28/2017
RXi Pharma (RXII) Granted Patent In Japan For Lead Clinical Candidate RXI-109 3/28/2017
Propanc Receives Patentability Opinion For Method Of Treating Cancer Stem Cells 3/28/2017
Innovus Pharma Announces Receipt Of Notice Of Intention To Grant Sensum+ European Patent 3/27/2017
Xenetic Biosciences Provides Update On Patent Portfolio Development 3/27/2017
Argentum Persists In Challenging The "Evergreening" Patent On UCB, Inc. (UCBJF.PK)'s VIMPAT 3/24/2017
Mount Tam Biotechnologies Announces That The Japan Patent Office Has Allowed A Key Patent For Lead Compound TAM-01 3/24/2017
Biogen (BIIB)'s Victory Over $4 Billion MS Patent Spat Makes Company an Even More Attractive M&A Target 3/24/2017
Egalet Announces Issuance Of New U.S. And International Patents For Guardian Technology 3/23/2017
Ampio Pharmaceuticals, Inc. (AMPE) Updates Intellectual Property And Regulatory Exclusivity Strategy To Support The Commercialization Of Ampion 3/23/2017
USPTO Grants Composition Of Matter Patent To Achillion (ACHN) For Small Molecule Complement Alternative Pathway Factor D Inhibitors 3/22/2017
GILUPI Extends Its Patent Portfolio 3/22/2017
Eagle Pharma (EGRX) Announces Three New Patents Issued For Bendeka 3/21/2017
IGC Files Patent For Cannabis-Based Combination Therapy For Treatment Of Eating Disorders 3/21/2017
Pulmatrix (PULM) Receives European Patent For Its Inhaled Drug Delivery Technology 3/21/2017
Cellectar Biosciences  (CLRB) Further Deepens Intellectual Property Portfolio With Patent Grant For PET Imaging PDC 3/21/2017
Palatin Tech (PTN) Receives Notice Of Allowance On Bremelanotide Methods Of Use Patent For Treatment Of Hypoactive Sexual Desire Disorder In Premenopausal Women 3/20/2017
Edico Genome Expands Intellectual Property Portfolio With An Additional Five Patents Issued For DRAGEN Platform 3/20/2017
Almirall Release: Thermi Defends Against Viveve’s Claims Of Patent Infringement 3/17/2017
Vyripharm Biopharma Issued Patent For Comprehensive Medical Cannabis Testing From Agriculture To Clinical Applications 3/17/2017
USPTO Rejects New Reexamination Request Against Celyad’s US Patent For Production Of Allogeneic TCR-Deficient CAR-T Cells 3/16/2017
Kadimastem Granted A Patent In The US For Treatment Of Neurodegenerative Diseases 3/16/2017
Synpromics Granted Key Patent In Synthetic Promoter Development 3/16/2017
aTyr Pharma Announces Issuance Of U.S. Patent That Extends Patent Protection Of Physiocrines Derived From 20 Out Of 20 Human tRNA Synthetases 3/15/2017
Patents Licensed To Synthon Relating To The CD47-SIRPa Pathway Resist Challenges In The U.S. And Europe 3/15/2017
Cell Design Labs Announces Issuance Of Broad Patent For Programmable Car-T Cells To Treat Cancer And Other Diseases 3/15/2017
Resverlogix (RVX.TO) Announces Receipt Of Notice Of Allowance From The United States Patent And Trademark Office 3/15/2017
Cell Design Labs Announces Issuance Of Broad Patent For Programmable Car-T Cells To Treat Cancer And Other Diseases 3/15/2017
Mucodel Pharma Announces Patent Allowance For Mucodel’s Co-Gel Buccal Naloxone (Exonal™) 3/15/2017
Tonix Pharma (TNXP) Receives Notice Of Allowance For New U.S. Patent Covering Composition And Manufacture Of TNX-102 SL 3/14/2017
InDex Pharmaceuticals AB Gets Patent For Additional DIMS Compounds Granted In The U.S. 3/14/2017
Newly Issued Japanese Patent For PDC Optical Agents Further Strengthens Cellectar Biosciences  (CLRB)’ Intellectual Property Portfolio 3/14/2017
Cura Pharmaceutical Co., Inc. Announces U.S. Patent Allowances For Its Oral Thin Film Technology For Manufacture And Use In Pet Products 3/14/2017
Protalex (PRTX) Significantly Strengthens Global Intellectual Property Portfolio For Proprietary Immunomodulatory Therapeutic 3/13/2017
Acorda (ACOR) Release: Patent Trials And Appeal Board (PTAB) Upholds Four AMPYRA Patents 3/10/2017
Mersana Adds To Antibody Drug Conjugate (ADC) Intellectual Property Portfolio With Issuance Of EP Patent 3/9/2017
Edwards Lifesciences Corporation (EW) Release: German Patent Court Issues Initial Decision 3/9/2017
Novelion (AEGR) Release: U.S. Patent Trial And Appeal Board Affirms Lomitapide Patents With Favorable IPR Decisions 3/7/2017
Supernus (SUPN) Announces Settlement With Zydus Pharmaceuticals (USA) Inc. On Trokendi XR Patent Litigation 3/7/2017
Teewinot Life Sciences' Subsidiary, Full Spectrum Laboratories, Ltd., Announced Today: Grant Of An Important U.S. Patent With Broad Claims To Biosynthetic Production Of Cannabinoids 3/7/2017
Edwards Lifesciences (EW) Gets Split Decision In UK Heart Valve Patent Spat With Boston Scientific (BSX) 3/3/2017
FUJIFILM Release: The UK High Court Of Justice (Patents) Rules In Fujifilm Kyowa Kirin Biologics' Favor On Rheumatoid Arthritis, Psoriasis And Psoriatic Arthritis Dosing Regimens For Adalimumab Are Obvious And Unpatentable 3/3/2017
Orexo (ORXOF) Commences Patent Infringement Litigation Against Actavis For Their Generic Versions Of Suboxone And Subutex Tablets In The U.S. 3/1/2017
CortControl Granted U.S. Patent For Human Fertility Methodology 3/1/2017
Prima Biomed (PRR.AX) Release: U.S.A. Patent Grants For IMP321 In Cancer 3/1/2017
European Patent Office To Grant CRISPR-Cpf1 Patent To Broad Institute, MIT, And Harvard 2/28/2017
On Generic Drugs, Patent 'Death Squads' And The Oscars 2/28/2017
Eagle Pharma (EGRX) Announces 11th Patent Issued For Bendeka 2/28/2017
Actinium (ATNM.OB) Announces Expansion Of Intellectual Property Portfolio With Notice Of Allowance For U.S. Patent Related To Actimab-A, Actimab-M And The Company’s Technology Platform 2/28/2017
Actinium (ATNM.OB) Announces Expansion Of Intellectual Property Portfolio With Notice Of Allowance For U.S. Patent Related To Actimab-A, Actimab-M And The Company’s Technology Platform 2/28/2017
Lexaria Bioscience Corp. (LXRP) Notice Of Patent In Australia For Cannabinoid Infused Edibles 2/28/2017
Botanix Announces Filing Of New Permetrex Product Patents 2/27/2017
Courtagen Receives Notice Of Allowance For A Genetically Targeted Pain Therapy Patent In The U.S. 2/23/2017
Soligenix (SNGX) Receives European Patent For Formulation Of Synthetic Hypericin To Treat Psoriasis 2/22/2017
Cleveland HeartLab LLC Adds New Patent To Its Extensive Intellectual Property Position For The Myeloperoxidase (MPO) Test, A Powerful Biomarker For Inflammation And Its Role In Major Cardiac Events 2/22/2017
How Much Is a CRISPR Patent License Worth? 2/21/2017
RDD Pharma Announces Patents Granted In Israel And EU 2/21/2017
Eagle Pharma (EGRX) Announces New Patents Issued For Bendeka 2/21/2017
Renova Therapeutics Release: U.S. Patent For Urocortin 2 Gene Constructs Issued 2/21/2017
Symbiotix Biotherapies Announces Issuance Of First Composition Of Matter Patent Covering A Microbiome-Derived Therapeutic Molecule 2/16/2017
CRISPR (CRSP), Intellia, Caribou Biosciences And ERS Genomics Provide Update On CRISPR/Cas9 U.S. Patent Interference Proceedings And Grants Of Corresponding Patents In The U.K. 2/16/2017
Spectro Scientific Wins U.S. Patent For Water Contamination Measurement Method Used In Its FluidScan Handheld Infrared Oil Analyzer 2/16/2017
The Winners And Losers In The CRISPR Patent Fight 2/16/2017
This is Why the Decision on Who Invented CRISPR Matters 2/16/2017
Insmed (INSM) Extends ARIKAYCE Intellectual Property Protection With Issuance Of New U.S. Patent 2/14/2017
ITL Pharma Receives United States Patent Protection For Trithroid Using Sustained Drug Release And Improved Product Stability 2/14/2017
Armetheon Announces Issuance Of A New U.S. Patent For Its Phase 2 Clinical Stage Novel Oral Anti-Arrhythmic Budiodarone 2/13/2017
Onxeo Receives USPTO Notice Of Allowance For A new AsiDNATM-Related Patent, Expanding Its IP Protection In The U.S. 2/13/2017
Koios Receives Favorable Ruling In Challenge To High-Cost Drug’s Patent 2/10/2017
ADM Tronics (ADMT) Launches Major Expansion Of Medical Device Design And Engineering Capabilities 2/10/2017
Replicel Life Sciences Announces European Patents For Its Innovative Dermal Injector Technologies 2/9/2017
SpinalCyte, LLC Announces New U.S. Patent 2/9/2017
Supernus (SUPN) Announces Issuance Of Eighth U.S. Patent Protecting Trokendi XR 2/8/2017
Perrigo (PRGO) Confirms Patent Challenge For Generic Version Of Onexton Gel 2/7/2017
Emmaus Life Sciences Receives Notice Of Allowance For Japanese Patent For Use Of L-Glutamine In Treatment Of Diabetes 2/7/2017
Sirbal To Receive Its Seventh Allowable US Patent 2/7/2017
TapImmune (TPIV) Expands Intellectual Property On PolyStart Platform For Use In Next-Generation T-Cell Vaccines 2/7/2017
Ace Laboratories Announces Licensing Of Resveratrol Patents 2/7/2017
Arch Therapeutics Announces Issuance Of Method-Of-Use Patent Covering Self-Assembling Peptidomimetics 2/3/2017
Teva (TEVA) Confirms Generic Victoza Patent Challenge In The United States 2/2/2017
Are Teva (TEVA)'s Best Days Behind It? 2/2/2017
How A 2015 Trial Sheds Light On The CRISPR Patent Case 2/2/2017
Emmaus Life Sciences Receives Notice Of Allowance For U.S. Patent For Use Of L-Glutamine In Treatment Of Diverticulosis 2/1/2017
Kitov (KTOV) Granted Notice Of Allowance From U.S. Patent & Trademark Office For KIT-302 2/1/2017
Bristol-Myers Squibb (BMY) Announces European Patent Office Decision On Sprycel 2/1/2017
Mylan (MYL) Wins U.S. District Court Ruling Related To Copaxone 40 mg/mL Patents 1/31/2017
Tyme Announces Issuance Of Second Core Platform Patent 1/31/2017
Momenta (MNTA) Announces District Court Decision To Invalidate Teva (TEVA) Patents In COPAXONE (Glatiramer Acetate Injection) 40 Mg/Ml Litigation 1/31/2017
Dimerix Key Patent Allowed In Japan For Use Of Lead Drug Candidate In The Treatment Of Kidney Disease 1/31/2017
Teva (TEVA) Confirms District Court Decision In COPAXONE 40 mg/mL Patent Trial 1/31/2017
Zogenix (ZGNX) Announces Issuance Of U.S. Patent for ZX008 In Dravet Syndrome 1/30/2017
Supernus (SUPN) Announces Issuance Of Seventh U.S. Patent Protecting Trokendi XR 1/30/2017
Vybion, Inc. Huntington's Disease Drug Patent Receives Track I Status 1/30/2017
Absorption Systems Release: U.S. Patent Issued For Company' IDAS2, A First-In-Class Test System For Fundamental Drug Properties 1/26/2017
Knopp Biosciences Release: Company Receives Key Patent Directed To Ion Channel Activators For Brain Disorders 1/26/2017
SIRAKOSS Release: UK Based Medical Device Company Announces Two New Patents Granted By The US Patent And Trademark Office 1/26/2017
Humanetics Release: Pharma Awarded Patent To Mitigate Erectile Dysfunction Associated With Prostate Cancer Radiotherapy 1/24/2017
Cellectar Biosciences  (CLRB) Release: Company Announces Additional U.S. Patent Granted For CLR 131 And CLR 125 In A Broad Range Of Solid Tumors 1/24/2017
Propanc Release: Company Provides Progress Update On Additional Patent Applications 1/24/2017
Aushon Biosystems Release: New U.S. Patent Allowance Granted To Company For Microarray Printing Of Complex Biological And Chemical Fluids 1/24/2017
EyeGate Pharma Release: Company Awarded Canadian Patent For Proprietary Iontophoretic Formulation And Use Of The Formulation For Ocular Delivery Of Dexamethasone Phosphate 1/23/2017
10X Genomics Release: Company Invalidates RainDance Technologies Patent 1/23/2017
Zenosense (ZENO) Release: New Patent Application For Additional MIDS Detection Method 1/23/2017
Vaxil BioTherapeutics Release: Company Expands Into Infectious Diseases With First U.S. Patent For MTbuVax 1/20/2017
Why Patent Protection In The Drug Industry Is Out Of Control 1/19/2017
Biocept, Inc. (BIOC) Release: Company Awarded Patent In Australia For The Use Of Antibodies In Microchannels To Capture Circulating Tumor Cells And Other Rare Cells 1/19/2017
Mithra Pharmaceuticals Release: Company Announces Us Patent Allowance For The Use Of Estetrol As Emergency Contraceptive 1/18/2017
Oncoinvent AS Patent Issues In The USA 1/18/2017
EyeTracking Release: Company Issued Key Patent 1/17/2017
Cephalogics Awarded A U.S. Patent For Its High-Density Diffuse Optical Tomography System 1/17/2017
Carestream Health Release: Company’s Successful R&D Efforts Earn 43 U.S. Patents During 2016; 52 Additional Patents In Other Countries 1/17/2017
joimax Release: Company Shows Strong Growth Trend Again In 2016 And Is Issued New Patents, The Company Now Holds Than 150 Patents And Trademarks Worldwide 1/16/2017
MonoSolRx LLC Release: Company Files Patent Infringement Suit Against BioDelivery (BDSI) 1/16/2017
Osseon Release: Company Receives New Patent 1/13/2017
Biotech Support Group Release: Patent Cites HemogloBind In Complement Mediation 1/12/2017
M Pharmaceuticals Release: Company Announces Plans To Develop A Drug Product For Treatment Of FSD 1/12/2017
Aralez Release: Pharma Announces Issuance Of Additional U.S. Patent For Yosprala 1/11/2017
LKC Technologies Release: Meddevice Company's Portable RETeval Electrodiagnostic Device and Sensor Strips Earn Two United States Patents 1/11/2017
Propanc Release: Company Receives Allowance Of Key Patent Application For Method Of Treating Solid Tumors In The U.S. 1/11/2017
Santalis Announces Notice Of Allowance Of A U.S. Patent For The Use Of East Indian Sandalwood Oil To Treat Clostridium Infections 1/9/2017
Court Grants Permanent Injunction For Infringement Of Amgen (AMGN)'s Repatha Patents 1/9/2017
Celyad Announces USPTO Decision To Uphold U.S. Patent For Production Of Allogeneic TCR-Deficient CAR-T Cells 1/9/2017
RegeneRx Biopharmaceuticals, Inc. (RGRX) Receives Notice Of Acceptance for Patent in Australia For Treatment of Neural Injury with Thymosin Beta 4. 1/9/2017
Amgen (AMGN) Shares Soar After Blocking Rivals From Selling Competing Cholesterol-Lowering Drug 1/6/2017
Iroko Pharma Announces Key Patent For VIVLODEX 1/6/2017
IMPAX Labs (IPXL) Confirms Patent Challenge Relating To Generic Aubagio (Teriflunomide) Tablets, 14 Mg 1/6/2017
Ascendia Pharmaceuticals Announces Issuance Of A New Patent On Its ASD-002 Program For Acute Coronary Syndrome 1/6/2017
SpinalCyte, LLC Receives New U.S. Patent 1/6/2017
Key Patent Is Issued Covering Protagonist (PTGX)' Alpha4Beta7 Integrin Peptide Inhibitors Including Oral Drug Candidate PTG-100 1/5/2017
Deinove Release: A First Innovative Antibiotic Candidate Patented 1/5/2017
Twenty-two New Patents Are Added To ViaCyte's Intellectual Property Portfolio 1/4/2017
Verseon (VSN.L) Granted U.S. Patents Covering Its Novel Serine Protease Inhibitors 1/4/2017
Sanofi (SNY), Regeneron (REGN) Lose Bid To Overturn Amgen (AMGN) Win In Patent Case 1/4/2017
Knopp Biosciences Receives Key Patent Directed To Treatment For Hypereosinophilic Syndromes, Asthma, And Other Eosinophilic Diseases 1/4/2017
Teewinot Life Sciences' Irish Subsidiary Full Spectrum Laboratories, Ltd. Secures A New U.S. Patent For Biosynthesis Of Cannabinoids 1/3/2017
Avenue Therapeutics Receives Notices Of Allowance For Patent Applications Covering Methods Of Administration For Intravenous Tramadol 1/3/2017
Drug Patents Expiring In 2017? It’s All Smoke And Mirrors 1/3/2017
Marina Biotech (MRNA) Granted European Claims Covering Bacteria Mediated Gene Silencing 1/3/2017
BioCardia Receives Another U.S. Patent Covering A Method Of Treating Heart Attack Tissue Damage With A Patient’s Own Progenitor Cells, Providing Further Protection To Phase III CardiAMP Program 12/27/2016
IntelliPharmaCeutics Announces Issuance Of U.S. And Canadian Patents Covering Aspects Of Its PODRAS Overdose Technology 12/21/2016
Cellectar Biosciences  (CLRB) Announces US And Japanese Patent Allowances For Diagnostic And Optical Imaging PDCs 12/20/2016
Leonhardt And Genovese File Patent For Bioelectric Controlled Expression Of PDGF A Powerful Organ Regeneration Cytokine 12/20/2016
Ogeda Announces Fezolinetant As INN And Issuance Of U.S. Patent For ESN364 12/20/2016
Kite Pharma (KITE) Announces Successful Defense Of Roberts Patent And Intent To Appeal U.S. Patent And Trademark Office Decision On A Narrow Patent Focused On Select CD28 CAR-T Products 12/19/2016
Pulmatrix Receives Patents Important To Its Inhaled Drug Delivery Technology 12/19/2016
Pivotal Evolva (EVE.SW) Stevia Sweetener Patent Receives U.S. Notice Of Allowance 12/19/2016
NanoBio Corporation Awarded U.S. Patent For RSV Vaccine 12/19/2016
Gilead (GILD) Sinks, Will Pay Rival $2.54 Billion for a Patent Dispute 12/19/2016



//-->